Glenmede Trust’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$13.2M Buy
43,222
+269
+0.6% +$82K 0.07% 284
2024
Q4
$14.3M Buy
42,953
+22,708
+112% +$7.54M 0.07% 284
2024
Q3
$6.76M Sell
20,245
-56,046
-73% -$18.7M 0.03% 409
2024
Q2
$31.4M Buy
76,291
+27,655
+57% +$11.4M 0.16% 125
2024
Q1
$19.7M Sell
48,636
-14,079
-22% -$5.69M 0.1% 209
2023
Q4
$19.2M Sell
62,715
-474
-0.8% -$145K 0.1% 202
2023
Q3
$15.3M Sell
63,189
-29,944
-32% -$7.25M 0.09% 236
2023
Q2
$17.8M Buy
93,133
+172
+0.2% +$32.9K 0.1% 213
2023
Q1
$17.5M Sell
92,961
-735
-0.8% -$138K 0.1% 217
2022
Q4
$19.9M Sell
93,696
-13,125
-12% -$2.79M 0.12% 190
2022
Q3
$16.8M Sell
106,821
-12,424
-10% -$1.95M 0.11% 210
2022
Q2
$17.8M Buy
119,245
+113,707
+2,053% +$17M 0.1% 221
2022
Q1
$905K Sell
5,538
-7,317
-57% -$1.2M ﹤0.01% 744
2021
Q4
$2.8M Buy
12,855
+327
+3% +$71.1K 0.01% 507
2021
Q3
$2.37M Buy
12,528
+18
+0.1% +$3.41K 0.01% 520
2021
Q2
$2.21M Buy
12,510
+228
+2% +$40.2K 0.01% 522
2021
Q1
$2.01M Sell
12,282
-925
-7% -$152K 0.01% 524
2020
Q4
$1.84M Buy
13,207
+2,770
+27% +$385K 0.01% 534
2020
Q3
$1.17M Sell
10,437
-2,395
-19% -$267K 0.01% 587
2020
Q2
$1.19M Sell
12,832
-34,616
-73% -$3.22M 0.01% 573
2020
Q1
$3.99M Hold
47,448
0.02% 491
2019
Q4
$3.99M Sell
47,448
-1,318
-3% -$111K 0.02% 491
2019
Q3
$4.1K Buy
48,766
+107
+0.2% +$9 0.02% 493
2019
Q2
$3.18K Buy
48,659
+86
+0.2% +$6 0.01% 558
2019
Q1
$2.86K Buy
48,573
+3,120
+7% +$184 0.01% 583
2018
Q4
$2.41K Buy
45,453
+30,193
+198% +$1.6K 0.01% 591
2018
Q3
$914K Buy
+15,260
New +$914K ﹤0.01% 765